New combo attack on brain metastases: radiation plus targeted pill shows promise
NCT ID NCT04923542
First seen Nov 15, 2025 · Last updated Apr 29, 2026 · Updated 24 times
Summary
This study tests whether adding the targeted drug abemaciclib to precise radiation (stereotactic radiosurgery) can better control breast cancer that has spread to the brain. It is for people with a specific type of breast cancer (HR+/HER2-). The goal is to see how long the cancer stays under control in the brain. About 31 participants will receive both treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
ACTIVE_NOT_RECRUITINGTampa, Florida, 33612, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Conditions
Explore the condition pages connected to this study.